CN1748784A - Process for producing ampeptide element - Google Patents

Process for producing ampeptide element Download PDF

Info

Publication number
CN1748784A
CN1748784A CNA2005100456138A CN200510045613A CN1748784A CN 1748784 A CN1748784 A CN 1748784A CN A2005100456138 A CNA2005100456138 A CN A2005100456138A CN 200510045613 A CN200510045613 A CN 200510045613A CN 1748784 A CN1748784 A CN 1748784A
Authority
CN
China
Prior art keywords
adds
eluent
mentioned
effluent
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2005100456138A
Other languages
Chinese (zh)
Other versions
CN1294986C (en
Inventor
高维明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100456138A priority Critical patent/CN1294986C/en
Publication of CN1748784A publication Critical patent/CN1748784A/en
Application granted granted Critical
Publication of CN1294986C publication Critical patent/CN1294986C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The technological process of producing amino peptide essence includes sorting hog nail, washing, hydrolysis, drying, crushing, superfine grinding, lixiviation to separate and resin exchange to purify, and has high bioavailability.

Description

Process for producing ampeptide element
Technical field:
What the present invention relates to is pharmaceutical technology, particularly the ampeptide elemente production method.
The prior art situation:
Ampeptide elemente is the treatment idiopathic thrombocytopenic purpura of the development eighties, leukopenia, and aplastic anemia also can be used for psoriatic biochemical drug.
Domestic existing process for producing ampeptide element is to adopt high-temperature hydrolysis process fully at present, and the hydrolyzed product convection drying is pulverized, and is processed into finished product.This process simple coarse fails effective ingredient in the raw material is carried out purification, causes the finished product active constituent content low, and bioavailability is low, and total nitrogen is 13%, and amino nitrogen accounts for 2% of total nitrogen.
Summary of the invention
The objective of the invention is to improve, the process for producing ampeptide element that a kind of method is easy, improve the active constituent content of bioavailability, raising product is provided at the deficiency of prior art ampeptide elemente production technology.
The inventive method is in former technology: Unguis Sus domestica is selected cleaning---on the basis of hydrolysis---drying---pulverizing, adopts micronizing, lixiviate separation, resins exchange technical method to reach purification, improves bioavailability.
Process of the present invention is:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder is pressed 1: 2-3 adds purified water, stirs, and last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, with above-mentioned mixed liquor in 1: the ratio of 7-8 adds 5% sodium hydroxide, stirs at interval lixiviate 20-24 hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying; With above-mentioned precipitate dried under reduced pressure, must make with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying: must make with extra care ampeptide elemente.
Though technology of the present invention has increased the processing technique step on the basis of former technology, the product effective ingredient polypeptide, the amino acid content that make through this technology improve, and bioavailability improves, and product quality has than much progress than former handicraft product.
Survey report is as follows:
Project 20040401 20040402 20040403
Character Faint yellow Faint yellow Faint yellow
Differentiate Be positive reaction Be positive reaction Be positive reaction
Microbial limit Up to specification Up to specification Up to specification
Total nitrogen 26.72% 26.52% 26.94%
Amino nitrogen 2.58% 2.53% 2.50%
Embodiment:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder was added purified water by 1: 2, stir, last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, above-mentioned mixed liquor is added 5% sodium hydroxide in 1: 8 ratio, stirred lixiviate 24 hours every one hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying with above-mentioned precipitate dried under reduced pressure, must be made with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying:, must make with extra care ampeptide elemente with drying under reduced pressure case drying.

Claims (1)

1, process for producing ampeptide element is characterized in that:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder is pressed 1: 2-3 adds purified water, stirs, and last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, with above-mentioned mixed liquor in 1: the ratio of 7-8 adds 5% sodium hydroxide, stirs at interval lixiviate 20-24 hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying; With above-mentioned precipitate dried under reduced pressure, must make with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying: must make with extra care ampeptide elemente.
CNB2005100456138A 2005-01-06 2005-01-06 Process for producing ampeptide element Expired - Fee Related CN1294986C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100456138A CN1294986C (en) 2005-01-06 2005-01-06 Process for producing ampeptide element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100456138A CN1294986C (en) 2005-01-06 2005-01-06 Process for producing ampeptide element

Publications (2)

Publication Number Publication Date
CN1748784A true CN1748784A (en) 2006-03-22
CN1294986C CN1294986C (en) 2007-01-17

Family

ID=36604561

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100456138A Expired - Fee Related CN1294986C (en) 2005-01-06 2005-01-06 Process for producing ampeptide element

Country Status (1)

Country Link
CN (1) CN1294986C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773660A (en) * 2010-03-17 2010-07-14 张大宇 Medicament containing anubi-polypeotide
CN101979656A (en) * 2010-11-11 2011-02-23 武汉远城科技发展有限公司 Method for extracting hoof peptide
CN103549249A (en) * 2013-10-11 2014-02-05 吕明 Purification technology for propolis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063874A (en) * 1991-02-07 1992-08-26 杭州肉类联合加工厂 From poultry hair or coffin, extract the method for soluble keratin
CN1129440C (en) * 2000-05-11 2003-12-03 齐鲁制药厂 Piles treating medicine and its prepn.
CN1204118C (en) * 2001-09-04 2005-06-01 叶小利 Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution
CN1208312C (en) * 2002-03-13 2005-06-29 何文义 New process for preparing compound amino acid by using animal hoof and foot

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773660A (en) * 2010-03-17 2010-07-14 张大宇 Medicament containing anubi-polypeotide
CN101773660B (en) * 2010-03-17 2011-08-31 李国� Medicament containing anubi-polypeotide
CN101979656A (en) * 2010-11-11 2011-02-23 武汉远城科技发展有限公司 Method for extracting hoof peptide
CN101979656B (en) * 2010-11-11 2012-06-06 武汉远城科技发展有限公司 Method for extracting hoof peptide
CN103549249A (en) * 2013-10-11 2014-02-05 吕明 Purification technology for propolis

Also Published As

Publication number Publication date
CN1294986C (en) 2007-01-17

Similar Documents

Publication Publication Date Title
CN112409132B (en) Method for separating inositol and by-products
CN101798273B (en) Valine purification method
Boonmee et al. Improved lactic acid production by in situ removal of lactic acid during fermentation and a proposed scheme for its recovery
CN106046248B (en) Cationic flocculant and preparation method thereof
CN101525306A (en) Method for extracting and separating natural taurine from octopus leftovers
CN1294986C (en) Process for producing ampeptide element
CN105348122A (en) Method for purifying L-alanine final mother liquor
CN1117752C (en) Method for purifying and crystallizing vitamin B2
CN1035000C (en) Method of extracting citric acid from citric acid fermentation liquor
CN1156464C (en) Refining process of electron level oxydiphenyl diformic anhydride
CN111499537B (en) Refining and purifying method of plant-derived ceramide extract
CN1775744A (en) Leucine extracting method
CN1056190C (en) Citric acid extracting process
CN109206486A (en) A kind of impurity and preparation method thereof of sulfuric acid Polymyxin B sulfate
CN111606856B (en) Method for separating carnosine and histidine
CN1229332C (en) Extraction process of 15N-L-phenylalanine
CN1217901C (en) High-yield manna sugar preparation process
CN1282639C (en) Continuous ion exchage extracting process for L-phenylalanine
CN109180512B (en) Method for removing glutamic acid from gamma-aminobutyric acid fermentation liquor
CN85109246A (en) The method for preparing crystalline L-glutamic acid and salt thereof
CN102382150B (en) Preparation method of high-purity mixed sodium deoxyribonucleotide
CN106591406B (en) Method for preparing bone gelatin by using ultrasonic-assisted enzyme method
CN104876856A (en) Method for preparing (R)-(+)-3-piperidinamine dihydrochloride by using resolution method
CN116478055A (en) Chiral refining method of aspartic acid
CN117417278A (en) Production method for producing ammonia three powder by mother liquor proportioning

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee